# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!



Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 21-30 of 496 results.
Effect of JKB-122 on Prednisolone and Azathioprine Induced Remission in Autoimmune Hepatitis (AIH)
Status: Not yet recruiting
Last Changed: Sep 01, 2020
First Received: May 01, 2020
Disease(s): Autoimmune Hepatitis
Intervention(s): JKB-122, Placebo
Study on the Prevalence of Hepatitis C In a psychiatRic Population
Status: Not yet recruiting
Last Changed: Oct 27, 2020
First Received: Oct 23, 2020
Disease(s): Hepatitis C
Intervention(s): Evaluation of the prevalence of HCV, HBV and HIV viral infections
A Mechanistic Study of GSK3228836 With Fine Needle Aspiration (FNA) in Participants With Chronic Hepatitis B
Status: Recruiting
Last Changed: Oct 08, 2020
First Received: Sep 10, 2020
Disease(s): Hepatitis B
Intervention(s): GSK3228836, Nucleos(t)ide therapy
Locations: GSK Investigational Site, Toronto, Ontario, Canada
A Randomized, Placebo-controlled Trial of Antroquinonol in Patients With Chronic Hepatitis B
Status: Recruiting
Last Changed: Oct 02, 2019
First Received: Oct 02, 2019
Disease(s): Chronic Hepatitis B
Intervention(s): Antroquinonol capsule 100mg, Antroquinonol capsule 200mg, Placebo oral capsule
Locations: Chung Shan Medical University hospital, Taichung, Taiwan
ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings
Status: Recruiting
Last Changed: Nov 21, 2019
First Received: Sep 26, 2018
Disease(s): Hepatitis C
Intervention(s): Campaign days
Locations: Coopers Cottage, Campbelltown Drug Health Services, Campbelltown, New South Wales, Australia
Rankin Court Treatment Centre, Darlinghurst, New South Wales, Australia
Liverpool Opioid Treatment Program, Liverpool, New South Wales, Australia
WSLHD Mount Druitt Drug Health OST Clinic, Mount Druitt, New South Wales, Australia
Lawrence Avenue Methadone Program (LAMP), Nowra, New South Wales, Australia
... and 4 other locations.
Alcoholic Hepatitis Network Observational Study
Status: Recruiting
Last Changed: Mar 04, 2020
First Received: Feb 22, 2019
Disease(s): Alcoholic Hepatitis
Locations: IU School of medicine, Indianapolis, Indiana, United States
University of Louisville, Louisville, Kentucky, United States
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
University Of Massachusetts, Worcester, Massachusetts, United States
Mayo Clinic, Rochester, New York, United States
... and 5 other locations.
IL-1 Signal Inhibition in Alcoholic Hepatitis
Status: Recruiting
Last Changed: Jun 04, 2020
First Received: Dec 13, 2018
Disease(s): Alcoholic Hepatitis
Intervention(s): Canakinumab 150mg/ml solution for injection, Placebo
Locations: University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom
Glasgow Royal Infirmary, Greater Glasgow & Clyde, Glasgow, United Kingdom
Queen Elizabeth University Hospital, Glasgow, United Kingdom
Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
Aintree University Hospital, Liverpool, United Kingdom
... and 13 other locations.
Immunogenicity and Persistence of Hepatitis B Vaccination in HIV-Infected Patients
Status: Not yet recruiting
Last Changed: May 24, 2019
First Received: May 24, 2019
Disease(s): Hepatitis B Vaccine
Intervention(s): 20 µg recombinant hepatitis B vaccine at months 0, 1, and 6, 20 µg recombinant hepatitis B vaccine at months 0, 1, 2, and 6, 60 µg recombinant hepatitis B vaccine at months 0, 1, 2, and 6
Locations: Shanxi Center for Disease Control and Prevention, Taiyuan, China
A Nation-wide Hospital-based Hepatitis B Registry:China Registry of Hepatitis B
Status: Recruiting
Last Changed: Nov 06, 2017
First Received: Apr 11, 2017
Disease(s): Chronic Hepatitis B
Locations: Beijing Ditan Hospital, Beijing, Beijing, China
Peking Union Medical College Hospital, Beijing, Beijing, China
Peking University First Hospital, Beijing, Beijing, China
Peking University People's Hospital, Beijing, Beijing, China
Beijing Tiantan Hospital, Beijing, Beijing, China
... and 41 other locations.
An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Tenofovir in Naive Patients With Chronic Hepatitis b
Status: Recruiting
Last Changed: Nov 12, 2019
First Received: Nov 08, 2019
Disease(s): Chronic Hepatitis b
Intervention(s): TDF tablet, QL-007
Locations: Southern Hospital of Southern Medical University, Guangzhou, Guangdong, China
The first hospital of Jilin university, Changchun, Jilin, China